<img alt="" height="1" width="1" />
Spiriva Inhaler Approved To Reduce Flares of COPD
Palm Beach Post
The US Food and Drug Administration has expanded approval for the Spiriva Handihaler (tiotropium bromide inhalation powder) to include reducing symptoms during flares of chronic obstructive pulmonary disease (COPD), makers Boehringer Ingleheim ...
Pfizer, Boehringer's Spiriva gets new FDA approvalBusinessWeek
Boehinger Ingelheim announces FDA approval for Spiriva HandiHalerDanbury News Times
FDA Approves Tiotropium Bromide Inhalation Powder for Reducing COPD ExacerbationDG News
Drug Store News (blog) -Earthtimes (press release)
all 31 news articles »
More...